RIV Capital Closing in on New York Acquisition, Loses $142 Million in Q2

RIV wrote down the value of the Etain acquisition due to uncertainty around New York's launch.

RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) posted a $142.3 million loss for its second quarter of fiscal 2023, but most of the losses were chalked up to a “goodwill impairment charge” as part of the upcoming acquisition of New York-based Etain – a deal that RIV Capital leadership said would give the firm a national foundation for future growth.

RIV took a $138.9 million write-down on its Etain acquisition deal, based on updated cash flows and “to account for the enhanced risk and uncertainty attached to the New York market,” the company reported.

The losses are an extreme increase from the same period last year, when RIV Capital lost just $1.2 million for the quarter that closed at the end of September. Year-to-date, RIV’s net loss totaled $145.8 million, compared with just $29.1 million a year ago.

Still, the company remains bullish, particularly due to the pending launch of the New York recreational cannabis market, even though Etain and the other nine licensed medical cannabis companies in the state are forbidden from participating in recreational sales for at least another three years, under draft regulations released on Nov. 21.

On that same date, however, New York regulators gave their final sign off to the Etain acquisition by RIV, which executives said will position the firm to do well in the New York cannabis wholesale market.

“Having cleared all regulatory hurdles, we are eager to complete the final closing of the Etain acquisition before the end of 2022,” RIV Capital CEO Mark Sims said in a news release. “Our expanding cultivation footprint designed to support the premium New York market provides RIV Capital with attractive wholesale opportunities.”

During the most recent quarter, RIV reported it signed a lease agreement with Zephyr for two indoor cultivation and manufacturing facilities that will total 75,000 square feet, and plans to partner with social equity cannabis growers in at least 10,000 square feet of canopy of that space.

RIV Capital also still has $165 million in cash, which it said it intends to use to continue expanding and acquiring other cannabis companies across the country.

John Schroyer


Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 4 hours

Despite Early Access for Out-of-State Brands, In-State Hope Remains

@GreenMarketRpt – 4 hours

Out-of-State Brands Already Entering New York Cannabis Market

@GreenMarketRpt – 3 days

Georgia Medical Cannabis Program Rules Delayed over Technicality

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.